Michael Tarnok

Director/Board Member at

Ionetix, Inc.

Net worth: 251 806 $ as of 2026-06-29

71 year

96 connections

Health Technology

Consumer Services

Health Services

Profile

Michael P.
Tarnok currently works at Ionetix, Inc., as Director.
Mr. Tarnok also formerly worked at Keryx Biopharmaceuticals, Inc., as Chairman from 2010 to 2016, Dyadic International, Inc., as Independent Director from 2024 to 2025, Global Health Council, Inc., as Director, and Pfizer Inc., as Senior Vice President-Finance from 1989 to 2007.
Mr. Tarnok received his Masters Business Admin degree from New York University and undergraduate degree from St. John's University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DYADIC INTERNATIONAL, INC. 0.77%	2025-06-19	281,033 ( 0.77% )	251 806 $	2026-06-29

Michael Tarnok active positions

Companies	Position	Start
Ionetix, Inc.	Director/Board Member	-

All active positions of Michael Tarnok

Former positions of Michael Tarnok

Companies	Position	End
DYADIC INTERNATIONAL, INC.	Chairman	2024-03-27
KERYX BIOPHARMACEUTICALS	Chief Executive Officer	2009-05-19
PFIZER INC.	Corporate Officer/Principal	2006-12-31
Global Health Council, Inc. Global Health Council, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as membership organization supporting and connecting advocates	Director/Board Member	-

See the detail of Michael Tarnok's experience

Training of Michael Tarnok

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Tarnok's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
Dyadic International, Inc. Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products	Health Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. John's University St. John's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Global Health Council, Inc. Global Health Council, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as membership organization supporting and connecting advocates	Commercial Services
Ionetix, Inc.